Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery

Anesthesia and Analgesia

Volumn 89, Issue 5, 1999, Pages 1108-1115

  Schmid, Edith R ^a   Bürki, Christoph ^a   Engel, Markus H C ^a   Schmidlin, Daniel ^a   Tornic, Mico ^a   Seifert, Burkhardt ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE; PROSTAGLANDIN E1; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INDEX; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE PERFORMANCE; HEART SURGERY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; VASODILATATION;

EID: 0344994493     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199911000-00007     Document Type: Article

References (29)

1. Frostell CG, Fratacci M-D, Wain JC, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing pulmonary vasoconstriction. Circulation 1991;83:2038-47.
2. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338:1173-4.
3. Young E. UHC Clinical Practice Advancement Center. Technology report: nitric oxide therapy. Oak Brook, IL: UHC Services Corporation, 1996.
4. Freeman B. Free radical chemistry of nitric oxide: looking at the dark side. Chest 1994;105:79S-84S.
5. Weinberger B, Fakhrzadeh L, Heck DE, et al. Inhaled nitric oxide primes lung macrophages to produce reactive oxygen and nitrogen immediates. Am J Resp Crit Care Med 1998;158:931-8.
6. Haraldsson A, Kieler-Jensen N, Ricksten S-E. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 1996;10:864-8.
7. 1 in the treatment of pulmonary hypertension: a new strategy in thoracic organ transplantation? Langenbecks Arch Chir 1996;Suppl 1:285-90.
8. Fullerton DA, Jones SD, Grover FL, McIntyre RC Jr. Adenosine effectively controls pulmonary hypertension after cardiac operations. Ann Thorac Surg 1996;61:1118-24.
9. 1, and sodium nitroprusside. J Heart Lung Transplant 1995;14:436-43.
10. Semigran MJ, Cockrill BA, Kacmarek R, et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994;24:982-8.
11. Kieler-Jensen N, Ricksten S-E, Stenqvist O, et al. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 1994;13:366-75.
12. Sitbon O, Brenot F, Denjean A, et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension: a dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 1995;151:384-9.
13. Prielipp RC, Rosenthal MH, Pearl RG. Vasodilator therapy in vasoconstrictor-induced pulmonary hypertension in sheep. Anesthesiology 1988;68:552-8.
14. McLean RF, Prielipp RC, Rosenthal MH, Pearl RG. Vasodilator therapy in microembolic porcine pulmonary hypertension. Anesth Analg 1990;71:35-41.
15. Sorkin EM, Brogden RN, Romankiewicz JA. Intravenous glyceryl trinitrate (nitroglycerin): a review of its pharmacological properties and therapeutic efficacy. Drugs 1984;27:45-80.
16. Piper PJ, Vane JR, Wyllie JH. Inactivation of prostaglandins by the lung. Nature 1970;225:600-4.
17. Fullerton DA, Jaggers J, Wollmering MM, et al. Variable response to inhaled nitric oxide after cardiac surgery. Ann Thorac Surg 1997;63:1251-6.
18. Girard C, Lehot JJ, Pannetier JC, et al. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992;77:880-3.
19. Gatecel C, Mebazaa A, Kong R, et al. Inhaled nitric oxide improves hepatic tissue oxygenation in right ventricular failure: value of hepatic venous oxygen saturation monitoring. Anesthesiology 1995;82:588-90.
20. Girard C, Durand PG, Vedrienne C, et al. Inhaled nitric oxide for right heart failure after heart transplantation. J Cardiothorac Vasc Anesth 1993;7:381-5.
21. Loh E, Stamler JS, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994;90:2780-5.
22. Bocchi EA, Bacal F, Aulor JO Jr, et al. Inhaled nitric oxide leading to pulmonary edema in stable severe left heart failure. Am J Cardiol 1994;74:70-2.
23. Hare JM, Shernan SK, Body SC, et al. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance. Circulation 1997;95:2250-3.
24. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 1995;92: 2198-203.
25. Hayward CS, Kalnins WV, Rogers P, et al. Effect of inhaled nitric oxide on normal human left ventricular function. J Am Coll Cardiol 1997;30:49-56.
26. 1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology 1989;70: 601-6.
27. Bender KA, Alexander JA, Enos JM, et al. Effects of inhaled nitric oxide in patients with hypoxemia and pulmonary hypertension after cardiac surgery. Am J Crit Care 1997;6:127-31.
28. Wagner F, Dandel M, Günther G, et al. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation. Circulation 1997; 96(Suppl II):II-291-6.
29. Bhorade S, Christenson J, O'Connor M, et al. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 1999;159:571-9.